Herzberg M C, Erickson P R, Kane P K, Clawson D J, Clawson C C, Hoff F A
Department of Preventive Sciences, School of Dentistry, University of Minnesota, Minneapolis 55455.
Infect Immun. 1990 Dec;58(12):4117-25. doi: 10.1128/iai.58.12.4117-4125.1990.
To isolate a more native, platelet-interactive macromolecule (class II antigen) of Streptococcus sanguis, cultured protoplasts were used as a source. Protoplasts were optimally prepared from fresh washed cells by digestion with 80 U of mutanolysin per ml for 75 min at 37 degrees C while osmotically stabilized in 26% (wt/vol) raffinose. Osmotically stabilized forms were surrounded by a 9-nm bilaminar membrane, as shown by transmission electron microscopy. Protoplasts were cultured in chemically defined synthetic medium and osmotically stabilized by ammonium chloride. Spent culture media were harvested daily for 7 days. Each day, soluble proteins were isolated from media, preincubated with platelet-rich plasma, and tested for inhibition of platelet aggregation induced by S. sanguis cells. Products released from S. sanguis protoplasts and reactive with an anti-class II antigen immunoaffinity matrix were able to inhibit S. sanguis-induced platelet aggregation. As resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, anti-class II-reactive protoplast products included silver-stained bands of 67, 79, 115, 216, and 248 kDa. The 115-kDa protein fraction was isolated by gel filtration and ion-exchange chromatography. This form of the class II antigen contained N-formylmethionine at its amino terminus. Rhamnose constituted 18.2% of the total residual dry weight and nearly half of its carbohydrate content. Diester phosphorus constituted 1% of this fraction. After trypsinization of the protoplast products from either preparation, a 65-kDa protein fragment was recovered. This protoplast protein fragment and the S. sanguis cell-derived 65-kDa class II antigen, previously implicated in the induction of platelet aggregation, were shown to be functionally and immunologically identical.
为了分离出一种更天然的、与血小板相互作用的血链球菌大分子(II类抗原),使用培养的原生质体作为来源。原生质体通过以下方法制备:将新鲜洗涤的细胞在37℃下用每毫升80 U的变溶菌素消化75分钟,同时在26%(重量/体积)的棉子糖中进行渗透稳定处理。如透射电子显微镜所示,渗透稳定形式被一层9纳米的双分子膜包围。原生质体在化学成分明确的合成培养基中培养,并用氯化铵进行渗透稳定处理。连续7天每天收集用过的培养基。每天从培养基中分离可溶性蛋白质,与富含血小板的血浆预孵育,并测试其对血链球菌细胞诱导的血小板聚集的抑制作用。从血链球菌原生质体释放并与抗II类抗原免疫亲和基质反应的产物能够抑制血链球菌诱导的血小板聚集。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分析,抗II类反应性原生质体产物包括67、79、115、216和248 kDa的银染条带。通过凝胶过滤和离子交换色谱法分离出115 kDa的蛋白质组分。这种形式的II类抗原在其氨基末端含有N-甲酰甲硫氨酸。鼠李糖占总残留干重的18.2%,几乎占其碳水化合物含量的一半。二酯磷占该组分的1%。对两种制备物的原生质体产物进行胰蛋白酶消化后,回收了一个65 kDa的蛋白质片段。该原生质体蛋白质片段与先前被认为与血小板聚集诱导有关的血链球菌细胞衍生的65 kDa II类抗原在功能和免疫上是相同的。